Abstract curved background pattern in light beige tones

Awards and Honors in Radiation Oncology

  • Teacher of the Year Award, Radiation Oncology Columbia University, 2008 – 2009
  • Teacher of the Year Award, Radiation Oncology New York University, 2007 – 2008
  • American Radium Society Travel Grant, 2007
  • Seattle Prostate Institute Prostate Brachytherapy Fellowship, 2007
  • Radiological Society of North America Roentgen Resident/Fellow Research Award, 2006
  • American Society for Therapeutic Radiology and Oncology Radiation Research Conference Travel Grant, 2006
  • Fourth Annual National Cancer Institute Young Investigator Workshop for Radiation Oncology Residents, Invited Attendee, 2005
  • American College of Radiation Oncology Travel Award Scholarship, 2005
Radiation Oncologist

Jinesh Shah

, M.D.

Dr. Jinesh N. Shah is a board-certified radiation oncologist with decades of experience in the field of oncology. He practices at Advanced Radiation Centers (ARC) of New York, serving in the leadership position of Clinical Director and providing expert cutting-edge care to patients in the Bronx East and Bronx West facilities.

Dr. Shah earned his Bachelor of Arts in Cognitive Neuroscience from Harvard University, graduating summa cum laude and being elected to the Phi Beta Kappa honor society. He then received his Medical Doctorate from Columbia University College of Physicians & Surgeons, where he was elected to the Alpha Omega Alpha honor society. He completed his residency training in radiation oncology at Columbia University Medical Center, where he served as Chief Resident.

Dr. Shah has held prestigious academic positions, including serving as an attending physician and assistant professor at Columbia University and NYU Medical Centers. He also served as Associate Director of the radiation oncology training program at Columbia University, teaching the next generation of radiation oncologists. He then went on to develop his own comprehensive private practice at Ocean Radiation Oncology, while also serving as Assistant Clinical Professor of Radiation Oncology at Columbia University Medical Center.

At ARC, Dr. Shah specializes in the treatment of prostate and breast cancers, utilizing the latest and most advanced radiation techniques including Image-Guided Volumetric Modulated Arc Radiation Therapy (IG-VMAT) and Stereotactic Body Radiation Therapy (SBRT). He serves on the national Solaris Prostate Cancer Committee and the local IMP Advanced Prostate Cancer Committee, using his recognized expertise to develop patient care standards for implementation at the national and local levels.

Dr. Shah also spearheads radiation oncology quality maintenance and improvement programs at ARC. He was additionally a member of the team that secured FDA approval of the BioProtect balloon rectal spacer device that has helped revolutionize rectal protection during prostate cancer radiotherapy. Due to his recognized leadership in oncology, he has been invited to serve on numerous Advisory Boards to guide industry leaders in the development and roll-out of cancer therapeutics.

Dr. Shah is wholeheartedly committed to providing his patients with individualized care using state-of-the-art treatment techniques and technologies, all while ensuring his patients always feel emotionally supported during their healing process. His energy, sense of humor, and compassion make his patients feel at ease while they receive the best radiation oncology care available.

He is fluent in Spanish and has proficiency in Gujarati.

Postgraduate Medical Training & Education

Columbia University Medical Center/New York-Presbyterian Hospital, New York, NY
July 2003 – June 2007
Resident in Department of Radiation Oncology
– Served as Chief Resident

Saint Vincent’s Catholic Medical Center, New York, NY
July 2002 – June 2003
Intern in the Department of Internal Medicine

Columbia University/College of Physicians and Surgeons, New York, NY
August 1998 – May 2002
M.D. Degree
– Elected to Alpha Omega Alpha honor society
– Recipient of Paul and Daisy Soros Fellowship (graduate education funding scholarship)

Harvard University, Havard College, Cambridge, MA
August 1994 – June 1998
B.A. Degree in Cognitive Neuroscience (Psychology and Biology)
– Graduated summa cum laude
– Elected to Phi Beta Kappa honor society

Journal Publications

Ng J, Shuryak I, Xu Y, Shah JN, Deutsch I, Chao KS, Brenner DJ, Burri RJ. Predicted risk of secondary lung malignancies from breast radiation therapy. International Journal of Radiation Oncology * Biology* Physics 2011;81(2), Supp: S246.

Guo S, Ennis RD, Bhatia S, Trichter F, Bashist B, Shah J, Chadha M. Assessment of nodal target definition and dosimetry using three different techniques: implications for re-defining the optimal pelvic field in endometrial cancer. Radiation Oncology 2010;5:59.

Wang TJ, Brisman R, Lu ZF, Li X, Isaacson SR, Shah JN, Yoshida EJ, Liu T. Image registration strategy of T1-weighted and FIESTA MRI sequences in trigeminal neuralgia Gamma Knife radiosurgery. Stereotactic and Functional Neurosurgery 2010;88(4):239-245.

Parhar PK, Duckworth T, Shah P, DeWyngaert K, Narayana A, Formenti SC, Shah JN. Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas. International Journal of Radiation Oncology * Biology * Physics 2010;78(2):379-384.

George I, Shah JN, Bacchetta M, Stewart A. Stentless bioprosthesis in a valved conduit: implications for pulmonary resection. Annals of Thoracic Surgery 2009;88(6):2022-2024.

Shah JN, Shao GS, Hei TK, Zhao YZ. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR. BMC Cancer 2008;8(1):284.

Shah JN, Liu C, Zhao Y, Formenti SC, Ibrahim S. Betaig-h3 tumor suppressor gene expression is absent in human low-grade follicular lymphoma but not in high-grade follicular lymphoma. International Journal of Radiation Oncology * Biology * Physics 2008;72(1), Supp S: S472.

Duckworth T, Parhar P, Shah P, DeWyngaert K, Narayana A, Formenti SC, Shah JN. Decreased temporal lobe dose with 5-Field IMRT for pituitary macroadenoma treatment. International Journal of Radiation Oncology * Biology * Physics 2008;72(1), Supp S: S236.

Bansal N, Cohen C, Shah JN, Schiff PB, Herzog TJ, Wright JD. Early metastatic spread after a complete response in locally advanced vulvar cancer treated with neoadjuvant chemoradiation. Journal of Reproductive Medicine 2008;53(9):700-702.

Gondi V, Deutsch I, Mansukhani M, O’Toole KM, Shah JN, Schiff PB, Katz AE, Benson MC, Goluboff ET, Ennis RD. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives. Urology 2007;69(3):541-546.

Shah JN, Trichter F, Bhatia S, Ennis RD. Inadequate coverage of iliac nodes with conventional, non-CT planning of endometrial cancer RT. International Journal of Radiation Oncology * Biology * Physics 2006;66(3), Supp S: S401-S402.

Shah JN, Wuu C-S, Katz AE, Laguna JL, Benson MC, Ennis RD. Improved biochemical control and clinical disease-free survival with intraoperative versus preoperative preplanning for transperineal interstitial permanent prostate brachytherapy. The Cancer Journal 2006;12(4):289-297.

Shah JN, Ennis RD. Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors. International Journal of Radiation Oncology * Biology * Physics 2006;64(3):817-824.

Shah JN, Ennis RD. Improved understanding of subtle rectal toxicity after prostate brachytherapy: results with a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors. International Journal of Radiation Oncology * Biology * Physics 2005;63(2), Supp 1:S316-S317.

Lazar RM, Fitzsimmons B-F, Marshall RS, Berman MF, Bustillo MA, Young WL, Mohr JP, Shah J, Robinson JV. Reemergence of stroke deficits with midazolam challenge. Stroke 2002;33:283-285.

Shah J. Should older patients with nonvalvular atrial fibrillation receive adjusted-dose warfarin for ischemic stroke prevention? P&S Medical Review 2001;7(2):15-20.

Lazar RM, Marshall RS, Young WL, Shah J, Constantine RC, Robinson J. Experimental reinduction of former stroke deficits with IV midazolam. Neurology 2000;54,Suppl 3:A42.

Laeng B, Shah J, Kosslyn S. Identifying objects in conventional and contorted poses: contributions of hemisphere-specific mechanisms. Cognition 1999;70(1):53-85.

Shah J. A socialization-mediated self-defeating model for evaluation of black-white performance differences on intelligence test batteries. Journal of Undergraduate Sciences 1996;3(2):89-101.

Oral Abstract Presentations

Wang TJ, Brisman R, Liu T, Shah JN. A novel approach of optimizing treatment shot angle in trigeminal neuralgia Gamma Knife radiosurgery. Radiological Society of North America 2009 Annual Meeting, Chicago, IL, November-December 2009.

Shah JN, Shao G, Zhao Y, Hei T. Hypermethylation of a novel tumor suppressor gene, Betaig-h3, in prostate cancer patient samples. American Radium Society 2007 Annual Meeting, Amsterdam, Netherlands, May 2007.

Poster Abstract Presentations

Vance W, Wen G, Zhao Y, Shah J, Wei Y, Chao C, Hei T. Deletion of the Betaig-h3 gene confers multi- agent chemotherapy resistance in a non-small cell lung cancer cell line. American Radium Society 2010 Annual Meeting, Cancun, Mexico, May 2010.

Wang TJC, Brisman R, Shah JN, Zhou J, Yoshida EJ, Liu T. Improved target delineation using T1- weighted and FIESTA MRI sequences in trigeminal neuralgia Gamma Knife radiosurgery. American Society for Therapeutic Radiology and Oncology 51st Annual Meeting, Chicago, IL, November 2009.

Ballas L, Wolden SL, Shuryak I, Shah JN, Balmir B, Chao KS, Brenner DJ. A comparison of involved field versus involved node radiation therapy in the pediatric Hodgkin lymphoma population: reduction in second malignancy risk. American Society for Therapeutic Radiology and Oncology 51st Annual Meeting, Chicago, IL, November 2009.

Wang T, Brisman R, Lu Z, Li X, Isaacson S, Shah J, Yoshida E, Liu T. Registration strategy in trigeminal neuralgia Gamma Knife radiosurgery using T1-weighted and FIESTA MRI sequences. American Association of Physicists in Medicine 51st Annual Meeting, Anaheim, CA, July 2009.

Shah JN, Liu C, Zhao Y, Formenti SC, Ibrahim S. Betaig-h3 tumor suppressor gene expression is absent in human low-grade follicular lymphoma but not in high-grade follicular lymphoma. American Society for Therapeutic Radiology and Oncology 50th Annual Meeting, Boston, MA, September 2008.

Duckworth T, Parhar P, Shah P, DeWyngaert K, Narayana A, Formenti SC, Shah JN. Decreased temporal lobe dose with 5-field IMRT for pituitary macroadenoma treatment. American Society for Therapeutic Radiology and Oncology 50th Annual Meeting, Boston, MA, September 2008.

Shah JN, Trichter F, Bhatia S, Ennis RD. Inadequate coverage of iliac nodes with conventional, non-CT planning of endometrial cancer RT. American Society for Therapeutic Radiology and Oncology 48th Annual Meeting, Philadelphia, PA, November 2006.

Liu T, Arias-Mendoza F, Mansukhani M, Benson MC, Schiff PB, Newhouse JH, Eum R, Zhang P, Johnson G, Shah JN, Cruz-Lobo JG, Rao Q, Brown TR, Kutcher GJ. Comparison of multi-modality prostate cancer imaging with ultrasound tissue-typing (UTT) and MRI/MRS to whole-mount pathology: a preliminary study. European Society for Therapeutic Radiology and Oncology 25th Annual Meeting, Leipzig, Germany, October 2006.

Shah JN, Trichter F, Bhatia S, Ennis RD. Superior treatment of iliac lymph nodes with CT-based planning of endometrial cancer RT. American Society for Therapeutic Radiology and Oncology Health Services/Outcomes Research in Oncology Symposium, San Diego, CA, September 2006.

Zhang P, Brisman R, Isaacson S, Watanabe Y, Shah J, Kutcher G. Is it necessary to adjust the prescription dose to compensate for Cobalt source decay of Gamma Knife radiosurgery? American Association of Physicists in Medicine 48th Annual Meeting, Orlando, FL, July-August 2006.

Shah JN, Ennis RD. Improved understanding of subtle rectal toxicity after prostate brachytherapy: results with a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors. American Society for Therapeutic Radiology and Oncology 47th Annual Meeting, Denver, CO, October 2005.

Shah JN, Katz AE, Wuu C, Liu T, Watanabe Y, Zhang P, Ennis RD. Biochemical and clinical outcomes of preoperative versus intraoperative brachytherapy preplanning for localized prostate cancer. American Society of Clinical Oncology/American Society for Therapeutic Radiology and Oncology 2005 Prostate Cancer Symposium, Orlando, FL, February 2005.

Liu T, Ennis RD, Schiff PB, Mansukhani M, Benson MC, Shah J, Sutton MW, Ko S, Wu L, Kutcher GJ. Prostate cancer imaging using an ultrasonic tissue-typing technique. American Society of Clinical Oncology/American Society for Therapeutic Radiology and Oncology 2005 Prostate Cancer Symposium, Orlando, FL, February 2005.

Invited Lectures

The Columbia Thoracic Tumor Board. Invited Panel Member. Extramural meeting in Garden City, NY. December 8, 2009.

The Columbia Thoracic Tumor Board. Invited Panel Member. Extramural meeting in Mount Kisco, NY. November 17, 2009.

The Columbia Thoracic Tumor Board. Invited Panel Member. Extramural meeting in Jersey City, NJ. May 5, 2009.

Chemotherapeutic Agents. Resident Radiation Biology Course. Columbia University Medical Center, New York, NY. April 6, 2009.

Hyperthermia. Resident Radiation Biology Course. Columbia University Medical Center, New York, NY. April 6, 2009.

Clinical Radiotherapy Experience

Intensity Modulated Radiation Therapy
TomoTherapy
Image-Guided Radiotherapy
Stereotactic Ablative Radiotherapy
Gamma Knife Radiosurgery
Three-Dimensional Conformal Radiation Therapy
Treatment Planning Systems (Eclipse, TomoTherapy)
CT Simulation
Total Body Irradiation

Professional Society Memberships

American Society for Radiology Oncology
American Society of Clinical Oncology
Alpha Omega Alpha
Phi Beta Kappa

Additional Languages

Spanish
Gujarati

Office Locations

Advanced Radiation Centers of New York: Bronx West (Bronx County)

  • ARC at BronxCare Hospital 1650 Grand Concourse Radiation Oncology Department, 1st Floor , Bronx, NY 10457
Fax: 718-583-6408

I am a heading

Ad litora torquent per conubia nostra, per inceptos himenaeos.sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis. Class aptent taciti sociosqu.
READ MORE

I am a heading

Forem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis.
READ MORE

I am a heading

Forem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis.
READ MORE

I am a heading

Forem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis.
READ MORE
View All Resources
Blue Dotted circle
Blue outlined circle on a white background

Request An Appointment